Economy & Business, Health & Environment, Politics

FDA Lets Pfizer Skip Vaxx Review Process…Again

WSJ reports that the FDA has been quietly meeting with drug makers to establish guidelines for expedited approval of the next generation of vaccines, if they’re needed (and that’s still a big “if”). According to the new rules the FDA is adopting, drugmakers are working on new vaccines and would be expected to meet standards similar to those required for authorization of boosters.

This means vaccine-makers would be spared the effort of conducting massive, time-consuming trials where they monitor a vaccine test group and a placebo group and wait to see which group reports fewer COVID casualties.

Instead, vaccine-makers could study the “immune response” elicited by the new jabs. Companies like Pfizer would have 3 months to create and test the jabs, with two or three weeks for the FDA to approve them. Read more…

You Might Also Like